Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (22473)	1/11/2007 5:33:09 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 52153

Recently, the Canadian TV networks have featured some R&D by a company called SemBioSys (or something close to that) which I believe is affilitated with the University of Alberta in Calgary. They issued two PRs this week. Here’s the first one on their lead program in plant-derived insulin: investorshub.com The second PR this week concerns SBS’ collaboration with MATK to develop a higher-yield process for DHA to replace MATK’s inefficient algae-based system. This is a pretty interesting company, IMO.